1-7 of 7
Nancy Bartlett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Jennifer L. Crombie, Tara Graff, Lorenzo Falchi, Yasmin H. Karimi, Rajat Bannerji, Loretta Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua Brody, Jeremy S. Abramson, Matthew Lunning, Nirav N. Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo Caimi, Ian Flinn, Alex Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad Kahl, Sonali Smith, Andrew Zelenetz, Lihua Elizabeth Budde, Martin Hutchings, Tycel Phillips, Michael Dickinson
Journal: Blood
Blood (2024) 143 (16): 1565–1575.
https://doi.org/10.1182/blood.2023022432
Published: 2024
Journal Articles

Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Claire Roddie, Lazaros J. Lekakis, Maria A. V. Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay G. R. Peddareddigari, Nushmia Khokhar, Robert Chen, Silvia Basilico, Meera Raymond, Frederick Arce Vargas, Kevin Duffy, Wolfram Brugger, Maeve A. O’Reilly, Leigh Wood, David C. Linch, Karl S. Peggs, Carlos Bachier, Elizabeth Lihua Budde, Connie Lee Batlevi, Nancy Bartlett, David Irvine, Eleni Tholouli, Wendy Osborne, Kirit M. Ardeshna, Martin A. Pule
Journal: Blood
Blood (2023) 141 (20): 2470–2482.
https://doi.org/10.1182/blood.2022018598
Published: 2023
Includes: Supplemental data
Journal Articles

Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411

Mitchell R Smith, Opeyemi Jegede, Peter Martin, Brian G. Till, Samir Parekh, David T. Yang, Lale Kostakoglu, Carla Casulo, Nancy Bartlett, Paolo F Caimi, Tareq Al Baghdadi, Kami J. Maddocks, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2022) 140 (Supplement 1): 186–188.
https://doi.org/10.1182/blood-2022-170381
Published: 2022
Journal Articles

Phase II Study of Denileukin Diftitox (ONTAK®) in Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma (B-NHL) and Poor Bone Marrow Reserve.

Myron S. Czuczman, MD, Lauren Pinter-Brown, Mary Jo Lechowicz, Nancy Bartlett, MD, Hillard Lazarus, John Lister, Andre Goy, MD, Stephen Kahanic, MD, Peter Rosen, MD, Mark Acosta, PharmD
Journal: Blood
Blood (2006) 108 (11): 4724.
https://doi.org/10.1182/blood.V108.11.4724.4724
Published: 2006
Journal Articles

Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival.

Tanya M. Wildes, MD, Kristan M. Augustin, PharmD, Ravi Vij, MD, Nancy Bartlett, MD, John F. DiPersio, MD, PhD, Steven M. Devine, MD
Journal: Blood
Blood (2005) 106 (11): 2086.
https://doi.org/10.1182/blood.V106.11.2086.2086
Published: 2005
Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

Andres Forero-Torres, Steven Bernstein, Ajay Gopal, Francine Foss, John Leonard, Joseph Rosenblatt, Nancy Bartlett, Anas Younes, David Fisher, Bruce Cheson, Matthew Carabasi, Gregory Bociek, Bruce Hart, Michael McDonald
Journal: Blood
Blood (2004) 104 (11): 2637.
https://doi.org/10.1182/blood.V104.11.2637.2637
Published: 2004
Journal Articles

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

David L. Grinblatt, M.D., Jeffrey Johnson, Donna Niedzwicki, Ph.D., David A. Rizzieri, M.D., Nancy Bartlett, M.D., Bruce D. Cheson, M.D.
Journal: Blood
Blood (2004) 104 (11): 3284.
https://doi.org/10.1182/blood.V104.11.3284.3284
Published: 2004